
James E zzso is an Assistant Professor in Medicine at Harvard Medical School zzso zzso as well as a Staff zzso in the Division of Hematologic Malignancies at zzso Cancer Institute zzso zzso The present research focus of the zzso laboratory concerns the discovery and zzso of zzso drugs targeting cancer gene zzso The clinical objective of the zzso group is to deliver novel zzso for human clinical investigation in zzso zzso zzso awards and honors include the Damon zzso Innovation zzso the Smith Family Award for Excellence in zzso Research, the Dunkin' Donuts Rising Star Award and the zzso Distinguished Excellence in zzso zzso He is a member of the American Society of Clinical Investigation, the American Society of zzso the American Chemical Society and the American Association of Cancer zzso His recent research has been published in zzso zzso Nature Chemical Biology and the Journal of the American Chemical zzso He has zzso more than 20 US Patent applications, licensed to five pharmaceutical companies, and is a scientific founder of zzso Pharmaceuticals, SHAPE Pharmaceuticals, zzso zzso and zzso zzso zzso received his AB from Harvard University, his MD from the University of Chicago zzso zzso and a zzso from Harvard Medical zzso He completed his zzso training in Internal Medicine at Brigham & Women's Hospital zzso zzso followed by a fellowship in Medical Oncology and zzso at zzso Cancer zzso Following additional post-doctoral training in zzso at Harvard University and the Broad Institute zzso zzso with Professor Stuart zzso zzso joined the research faculty of zzso in zzso zzso conducted by Hannah zzso Assistant zzso zzso 

